Drug intelligence / Profile preview

Alantel

Development stage: Unknown
Lead developer: Nakafarma
Modality: Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules, Drug Delivery Systems
Administration: Topical

Overview

Alantel is a marketed topical cream based on natural products, intended for the treatment of dermatitis and other skin conditions. It is formulated to provide anti-inflammatory, soothing, and protective effects on the skin. The product appears to be used primarily for dermatological purposes such as relieving symptoms of dermatitis, likely through moisturizing and supporting skin barrier function. The exact mechanism of action is not fully detailed in public sources but may involve anti-inflammatory activity from its natural ingredients[2]. There are no indications that it contains pharmaceutical actives like corticosteroids or immunomodulators.

Brand names: Alantel
Other names: Alantel

Beyond the preview

Go deeper on Alantel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alantel.